Mycoplasma genitalium Antimicrobial Resistance in Community and Sexual Health Clinic Patients, Auckland, New Zealand

Our retrospective study compared genotypic antimicrobial resistance in Mycoplasma genitalium-positive specimens collected from 48 community and 33 sexual health clinic (SHC) patients. Macrolide resistance was similar in community (75%) and SHC (76%) patients. We observed no significant difference in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Emerging infectious diseases 2020-02, Vol.26 (2), p.332-335
Hauptverfasser:	Vesty, Anna, McAuliffe, Gary, Roberts, Sally, Henderson, Gillian, Basu, Indira
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Ambulatory care facilities Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Antibacterial agents Antibiotics Antimicrobial agents Antimicrobial Resistance in Azithromycin bacteria bacterial infections Care and treatment Deoxyribonucleic acid Dispatch DNA Drug resistance Drug Resistance, Bacterial Female Fluoroquinolones - pharmacology Fluoroquinolones - therapeutic use Genetic testing genotypic antimicrobial resistance Humans Immunology in Community and Sexual Health Clinic Patients, Auckland, New Zealand Infection Infections Infectious Diseases Life Sciences & Biomedicine Male Microbial drug resistance Moxifloxacin Mutation Mycoplasma genitalium Mycoplasma genitalium - drug effects Mycoplasma genitalium - isolation & purification Mycoplasma Infections - drug therapy Mycoplasma Infections - epidemiology New Zealand - epidemiology Patients quinolone resistance-determining region Residence Characteristics Retrospective Studies RNA Science & Technology Sexual Health Sexually transmitted diseases sexually transmitted infections STD Urine Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Our retrospective study compared genotypic antimicrobial resistance in Mycoplasma genitalium-positive specimens collected from 48 community and 33 sexual health clinic (SHC) patients. Macrolide resistance was similar in community (75%) and SHC (76%) patients. We observed no significant difference in fluoroquinolone resistance between community (19%) and SHC (27%) patients (p = 0.66).
ISSN:	1080-6040 1080-6059
DOI:	10.3201/eid2602.190533